共 50 条
- [31] Healthcare Resource Use and Associated Costs in the Three Years Following the Initial Diagnosis of Diabetic or Idiopathic Gastroparesis: A Retrospective Claims Analysis [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S686 - S686
- [32] Safety and Efficacy of Highly Selective 5-HT4 Agonist (Velusetrag, Felcisetrag, Prucalopride) for Diabetic/Idiopathic Gastroparesis-Systematic Review and Meta-Analysis of Randomized Controlled Trials [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S489 - S490
- [34] Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 (10): : 1069 - +
- [36] Pilot Study of the Safety, Feasibility, and Efficacy of Continuous Glucose Monitoring (CGM) and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG): A Multicenter, Longitudinal Trial by the NIDDK Gastroparesis Clinical Research Consortium (GPCRC) [J]. GASTROENTEROLOGY, 2015, 148 (04) : S64 - S64